From the Journals

NLR useful for predicting 1-year mortality in PBC patients


 

FROM BMJ OPEN

An elevated baseline neutrophil-to-lymphocyte ratio (NLR) was associated with a poor 1-year mortality rate in hospitalized primary biliary cholangitis (PBC) patients, according to Lin Lin, MD, of Tianjin (China) Medical University General Hospital and the Tianjin Institute of Digestive Diseases and associates.

A retrospective analysis of 88 PBC patients hospitalized between June 2009 and January 2014 was performed for the study. NLR was a significant predictor of survival, with an odds ratio of 1.5, a sensitivity of 100%, and a specificity of 67.1%. A baseline NLR value of 2.18 was selected as the cutoff for 1-year mortality. Of the 33 patients above this value at initial hospitalization, 6 died, whereas none of the 55 patients below this value died.

The results of the retrospective study were confirmed in a prospective 1-year cohort that included 63 people with PBC. The patients with a baseline NLR of less than 2.18 had significantly longer survival times than those who had a baseline NLR of 2.18 or higher.

“NLR – an affordable, widely available and reproducible index – is closely related to short-term mortality in patients with PBC. Further studies are warranted to externally cross-validate our findings in other populations,” the investigators concluded.

Find the full study in BMJ Open (2017. doi: 10.1136/bmjopen-2016-015304).

Recommended Reading

Prior resections increase anastomotic leak risk in Crohn’s
MDedge Internal Medicine
New C. difficile drug shows promise
MDedge Internal Medicine
Blood markers can detect early pancreatic cancer
MDedge Internal Medicine
Liver cancer risk lower after sustained response to DAAs
MDedge Internal Medicine
FDA approves new treatment for adults with HCV
MDedge Internal Medicine
Bowel prep score helps predict missed polyps
MDedge Internal Medicine
EUS beats MRCP on sensitivity for bile duct stones
MDedge Internal Medicine
Fujifilm issues recall to update ED-530XT duodenoscopes
MDedge Internal Medicine
New cryoballoon treatment eradicated esophageal squamous cell neoplasias
MDedge Internal Medicine
Acute liver failure in the ED
MDedge Internal Medicine